Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: J Pain. 2022 Mar 10;23(7):1245–1255. doi: 10.1016/j.jpain.2022.03.003

Table 2.

Means and standard deviations for treatment outcomes at each time point.

Baseline Post-Tx Follow-up
Outcomes M SD M SD M SD
Pain-related disability* 48.33 21.84 44.48 22.52 44.45 23.40
Pain intensity 5.86 1.66 5.64 1.54 5.45 1.66
Global health*,** 34.84 7.38 36.87 8.45 38.04 8.67
Depression 57.60 11.10 57.91 10.63 56.81 11.80
Anxiety** 54.66 12.24 52.80 11.59 51.37 12.79
Fatigue* 44.58 18.24 48.71 15.70 47.79 18.94
Positive affect 14.21 4.44 14.27 6.01 14.67 5.36
Negative affect*,** 13.01 4.63 10.73 5.26 11.59 5.12
Executive functioning** 60.01 10.61 58.69 11.00 58.03 12.19

Notes.

*

Statistically significant change from pre-treatment to post-treatment (p < .05).

**

Statistically significant change from pre-treatment to follow-up (p < .05).